Pharma White Papers

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we will discuss these five best practices for life science companies to deliver effective multichannel experiences: 1. Ensuring reliable customer data2. Aligning communication channels3. Creating a high-leverage…
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more patient- centric models for reporting, analyzing and monitoring of safety data. However, there is no magic pill or solution to the various challenges facing the industry…
As the healthcare landscape moves increasingly toward outcome-based treatment approaches, the need to gather and analyze real-world outcome data has become paramount to gauging medication effectiveness and subsequently recruiting prescribers as brand advocates. This study outlines a feedback program that provides prescribers with patient results of their treatment experience in…
Biological medicines have made substantial contributions to the treatment of many chronic and serious diseases and are expected to provide significant therapeutic benefits to many patients who would otherwise have had limited treatment options. Increasingly aging populations and this growing burden of chronic diseases have put tremendous pressure on healthcare…
What are key challenges with treatment adherence among rare disease patients and how can we improve self-management of their condition? In a recent White Paper, Atlantis Healthcare examines the complex landscape of rare disease and addresses how health psychology frameworks can identify barriers and facilitators of Tx adherence to drive…
Page 1 of 4

Subscribe To Our Newsletter

Security Q:How many eyes has a typical person? (ex: 1)
Name:
Email: